Gore Excluder Studied in Brazil to Treat Thoracoabdominal Aortic Aneurysms


November 13, 2014—Gore & Associates announced that the first two patients were enrolled in the Gore Thoracoabdominal Aortic Aneurysm clinical study by Pierre Galvagni Silveira, MD, who is from the Federal University of Santa Catarina in Florianopolis, Brazil.

This initial feasibility study of the Gore Excluder thoracoabdominal branch endoprosthesis will assess the safety of the device implantation procedure in the treatment of abdominal aortic aneurysms encroaching on or involving visceral branch vessels. Gore intends to follow this Phase 1 clinical study in Brazil with an early feasibility study in the United States.

According to the company, the system of devices is designed to provide physicians with a complete off-the-shelf endovascular solution for aortic aneurysms encroaching on or involving the visceral section of the aorta.

The Gore Excluder thoracoabdominal branch endoprosthesis includes four precannulated portals for placement of stent graft branches for the visceral branch vessels, intended to enable a faster, more precise implant. The device is deployed via an intuitive staged delivery system that allows interventionists to reposition the partially deployed graft to aid in selective catheterization of the branches.

In Gore’s press release, Dr. Galvagni Silveira commented, “Treating aortic aneurysms encroaching on or involving visceral branch vessels is one of the most challenging endovascular procedures. The Gore Excluder thoracoabdominal branch endoprosthesis is designed to provide a long-term, durable solution to these challenging anatomical problems and is the only ‘all-in-one’ precannulated system developed exclusively for this purpose.”


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.